{
    "organizations": [],
    "uuid": "aee95051660555fbe5f88c09626f62605df99796",
    "author": "",
    "url": "https://www.reuters.com/article/brief-idera-pharma-files-definitive-prox/brief-idera-pharma-files-definitive-proxy-statement-over-with-pending-merger-with-biocryst-idUSFWN1RF072",
    "ord_in_thread": 0,
    "title": "BRIEF-Idera Pharma Files Definitive Proxy Statement Over With Pending Merger With Biocryst",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 2, 2018 / 12:39 PM / Updated 2 minutes ago BRIEF-Idera Pharma Files Definitive Proxy Statement Over With Pending Merger With Biocryst Reuters Staff \nApril 2 (Reuters) - Idera Pharmaceuticals Inc : \n* IDERA PHARMACEUTICALS FILES DEFINITIVE PROXY STATEMENT IN CONNECTION WITH PENDING MERGER WITH BIOCRYST PHARMACEUTICALS \n* ‍BOARD OF DIRECTORS RECOMMEND THAT ALL STOCKHOLDERS VOTE “FOR” MERGER PROPOSAL AS WELL AS ALL OTHER IDERA PROPOSALS​  ",
    "published": "2018-04-02T15:36:00.000+03:00",
    "crawled": "2018-04-02T15:48:36.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharma",
        "file",
        "definitive",
        "proxy",
        "statement",
        "pending",
        "merger",
        "biocryst",
        "reuters",
        "staff",
        "april",
        "reuters",
        "idera",
        "pharmaceutical",
        "inc",
        "idera",
        "pharmaceutical",
        "file",
        "definitive",
        "proxy",
        "statement",
        "connection",
        "pending",
        "merger",
        "biocryst",
        "pharmaceutical",
        "director",
        "recommend",
        "stockholder",
        "vote",
        "merger",
        "proposal",
        "well",
        "idera"
    ]
}